The impact of small intestinal bacterial overgrowth on the efficacy of fecal microbiota transplantation in patients with chronic constipation

• Published in: mBio 2024-08, Vol.15 (10), p.e0202324
• Main Authors: Wang, Le, Xu, Yue, Li, Long, Yang, Bo, Zhao, Di, Ye, Chen, Lin, Zhiliang, Cui, Jiaqu, Liu, Yunkun, Zhu, Wanyong, Li, Ning, Tian, Hongliang, Chen, Qiyi
• Format: Article
• Language: English
• Subjects: chronic constipation; Clinical Microbiology; efficacy; fecal microbiota transplantation; Research Article; small intestinal bacterial overgrowth
• ISSN: 2150-7511; 2150-7511
• DOI: 10.1128/mbio.02023-24

To investigate the impact of Small Intestinal Bacterial Overgrowth (SIBO) on the efficacy of Fecal Microbiota Transplantation (FMT) in patients with chronic constipation, our research team included 218 patients with chronic constipation treated with FMT. Based on the results of the SIBO breath test, the patients were divided into two groups: the constipation with SIBO group (SIBO) and the constipation without SIBO group (non-SIBO). The efficacy of the two groups was evaluated using constipation-related scoring scales. At the same time, feces and small intestinal fluid samples were collected from both groups before and after FMT to compare the changes in the intestinal microbiota through 16S rRNA sequencing. In this study, it was found that the clinical efficacy of FMT in the SIBO group was superior to that in the non-SIBO group. After FMT treatment, both groups showed a significant increase in bowel frequency and improvement in stool characteristics. Abdominal symptoms, rectal symptoms, and defecation symptoms were significantly alleviated ( < 0.05), and patients' quality of life was significantly enhanced ( < 0.05). After FMT, except for the Constipation Assessment Scale scores, other scale scores showed significant differences between the two groups, the SIBO group scoring significantly better than the non-SIBO group ( < 0.05). After FMT, there were minor changes in the colonic microbiota but more substantial changes in the small intestinal microbiota. At baseline, the SIBO group had a higher abundance of , and lower abundances of and compared to the non-SIBO group. Chronic constipation patients with SIBO have a better response to FMT than those without SIBO. Existing studies have rarely considered the impact of the small intestine's microbial state on the efficacy of fecal microbiota transplantation (FMT), nor have they extensively explored the effect of the small intestine's microbial state on the recovery of colonic motility. Therefore, this study investigates the influence of small intestinal bacterial overgrowth (SIBO) on the efficacy of FMT in treating constipation, specifically the impact of the microbial state of the small intestine on the restoration of colonic homeostasis, and consequently on the recovery of colonic motility.